Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00472992 · ClinicalTrials.gov registry record
Pregnancy Exposure Registry for Tysabri®
A clinical trial of Multiple Sclerosis and Pregnancy, sponsored by Biogen.
- Completed
- Registry status
- 376
- Enrollment target
- 1
- Study location
NCT00472992: Completed study of Multiple Sclerosis and Pregnancy, sponsored by Biogen.
NCT00472992 is a study of Multiple Sclerosis and Pregnancy that has completed, run by Biogen. The registered enrollment target is 376 participants, below the 584-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00472992, a study of Multiple Sclerosis and Pregnancy, has completed, sponsored by Biogen.
- COMPLETED
- Registry status
- 376 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of the Registry was to evaluate the outcomes of pregnancy in women with Multiple Sclerosis (MS) or Crohn's Disease (CD) who were exposed to TYSABRI® at any time within 90 days prior to first day of Last Menstrual Period (LMP) or during pregnancy.
Conditions Studied
Study Locations (1)
West Virginia
- United BioSource Corporation - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 376 participants |
| Start Date | 2007-01 |
| Est. Completion | 2012-07 |
What the finished NCT00472992 record still lists
NCT00472992 is an observational study that tracks outcomes without assigning an intervention. The registered 376 participants enrollment target is mid-sized for trials with a published cap, below the 584-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (36% lower).
The record links to 4 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 0 interventions.
NCT00472992 reports a single indexed study location in West Virginia.
Frequently Asked Questions
What is clinical trial NCT00472992 about?
NCT00472992 is a clinical study titled "Pregnancy Exposure Registry for Tysabri®". The primary objective of the Registry was to evaluate the outcomes of pregnancy in women with Multiple Sclerosis (MS) or Crohn's Disease (CD) who were exposed to TYSABRI® at any time within 90 days prior to first day of Last Menstrual Period (LMP) or during pregnancy.
What is the current status of trial NCT00472992?
This trial is currently completed. The enrollment target is 376 participants. The study started on 2007-01. Estimated completion is 2012-07.
What conditions does trial NCT00472992 study?
This clinical trial studies the following conditions: Multiple Sclerosis, Pregnancy, Crohn's Disease, Prenatal Exposure.
Who is sponsoring clinical trial NCT00472992?
This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00472992 being conducted?
This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00472992's enrollment target sits among peer trials
376 51st of 315 higher than 265 of 315 other Multiple Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Vancomycin Study in Multiple Sclerosis (MS)
RECRUITING · Phase 1
-
IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
RECRUITING
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03102125 · 376 participants · Phase 4
Allograft Dysfunction in Heart Transplant
- NCT05055297 · 376 participants · NA
SELUTION4BTK Trial
- NCT05912647 · 376 participants · NA
Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes
- NCT05963971 · 376 participants · NA
A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia